Search

everythinglearnresearchcommunity

for

Search:↓

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hormone therapy for trans individuals is effective and generally safe in the short term.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

A systematic approach is crucial for managing hair loss in women.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Menopause affects hair and skin; more research needed for treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

African American women report more hair issues and use different hair care practices than Caucasian women, and have different hair and scalp characteristics.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.